Reports Q2 revenue $458.49M, consensus $450.78M. EPS includes the impact of the 65c per share non-cash charge related to the previously announced Genesis restructuring. Ted Wahl, CEO, stated, “Second quarter growth exceeded our expectations. New client wins and higher retention drove our organic growth, and we have carried that positive momentum into the back half of the year. Despite the previously announced Genesis news and resulting impact on our Q2 reported results, our 2025 growth plans and cash flow outlook remain strong. We are confident that continuing to execute on our strategic priorities, supported by our strong business fundamentals, will enable us to further accelerate growth, while delivering sustainable, profitable results.”
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCSG:
- Is HCSG a Buy, Before Earnings?
- Healthcare Services Responds to Genesis HealthCare Bankruptcy
- Healthcare Services sees 62c Q2 charge from Genesis bankruptcy
- Healthcare Services affirms 2025 revenue growth outlook of mid-single digits
- Healthcare Services down 4% after estimating Genesis bankruptcy impact